Interparfums (NASDAQ:IPAR) & USANA Health Sciences (NYSE:USNA) Head-To-Head Comparison

USANA Health Sciences (NYSE:USNAGet Free Report) and Interparfums (NASDAQ:IPARGet Free Report) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

Volatility & Risk

USANA Health Sciences has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500.

Profitability

This table compares USANA Health Sciences and Interparfums’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
USANA Health Sciences 0.96% 6.21% 4.50%
Interparfums 11.32% 15.47% 10.82%

Earnings & Valuation

This table compares USANA Health Sciences and Interparfums”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
USANA Health Sciences $925.26 million 0.46 $10.76 million $0.47 48.72
Interparfums $1.49 billion 2.68 $168.39 million $5.27 23.70

Interparfums has higher revenue and earnings than USANA Health Sciences. Interparfums is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

54.2% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Comparatively, 43.7% of Interparfums shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations and price targets for USANA Health Sciences and Interparfums, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences 1 1 0 0 1.50
Interparfums 0 3 4 1 2.75

Interparfums has a consensus target price of $116.17, suggesting a potential downside of 7.01%. Given Interparfums’ stronger consensus rating and higher probable upside, analysts plainly believe Interparfums is more favorable than USANA Health Sciences.

Summary

Interparfums beats USANA Health Sciences on 14 of the 15 factors compared between the two stocks.

About USANA Health Sciences

(Get Free Report)

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

About Interparfums

(Get Free Report)

Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, and Dunhill, Lacoste names. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.